NEU: Phase 2 Pitt Hopkins Trial Results Exceed Expectations
Neuren Pharmaceuticals (NEU) has released the highly anticipated Phase 2 trial results for NNZ-2591 in Pitt Hopkins syndrome, and the data has significantly surpassed market expectations.
Broker Expectations:A broker analysis outlined three potential outcomes:
- Bull Case: Clear, statistically significant improvements across most/all endpoints, validating the drug's IGF-1 mechanism and its potential as a platform treatment for multiple neurodevelopmental disorders. This scenario anticipated a 15-20% share price increase.
- Base Case: Good but not exceptional data, suggesting some clinical impact and a modest 0-10% share price rise.
- Bear Case: No clinical impact, potentially causing a 20% drop in share price.
Delivered Results:NEU's announcement confirmed statistically significant improvements in all four efficacy measures specific to Pitt Hopkins syndrome, as assessed by both clinicians and caregivers (p<0.05). The Clinical Global Impression of Improvement (CGI-I) mean score was 2.6, and the Caregiver Overall Impression of Change (CIC) mean score was 3.0. Importantly, NNZ-2591 demonstrated an excellent safety and tolerability profile with no severe adverse events.
Impact:The results align with the bull case, suggesting a likely 15-20% increase in NEU's share price. This outcome not only strengthens confidence in NNZ-2591’s potential but also positions NEU favorably for future developments and potential big pharma interest.
- Forums
- ASX - By Stock
- Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
NEU: Phase 2 Pitt Hopkins Trial Results Exceed...
-
- There are more pages in this discussion • 119 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.86 |
Change
0.560(2.90%) |
Mkt cap ! $2.538B |
Open | High | Low | Value | Volume |
$19.80 | $20.00 | $19.40 | $3.777M | 191.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1060 | $19.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.87 | 209 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1060 | 19.830 |
8 | 6809 | 19.790 |
1 | 2736 | 19.740 |
1 | 1108 | 19.710 |
3 | 1623 | 19.700 |
Price($) | Vol. | No. |
---|---|---|
19.890 | 708 | 2 |
19.900 | 1450 | 1 |
19.910 | 4224 | 3 |
19.920 | 915 | 1 |
19.950 | 434 | 1 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |